Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay
Dichloroacetate (DCA) represents the first targeted therapy for pyruvate dehydrogenase complex deficiency; it is metabolized by glutathione transferase zeta1 (GSTZ1). Variation in the GSTZ1 haplotype is the principal variable influencing DCA kinetics and dynamics in humans. We aimed to develop a sen...
Saved in:
Published in | Genetic testing and molecular biomarkers Vol. 22; no. 4; p. 266 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.04.2018
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!